This story originally appeared on InvestmentNews. The global sustainable debt market grew 29% to a record $732 billion last year, helped by an explosion of bond issuance for social projects amid fallout from the pandemic, according to BloombergNEF. “Sustainability continues to rise up on the agenda for investors, businesses and …Read More »
This story originally appeared on MarketWatch. Moderna’s Covid-19 vaccine has been authorized for emergency use by the U.K. regulator, bringing a third shot to the country that is battling a surge in coronavirus cases. The Medicines and Healthcare products Regulatory Agency, or the MHRA, approved the two-shot vaccine developed by …Read More »
(This story is for CNBC PRO subscribers only.) We’re just seven days into the New Year, and Credit Suisse is already raising its forecast based on supportive Democratic policies and pent up demand once things return to normal from Covid. On Thursday the firm, led by chief U.S. equity strategist Jonathan Golub, …Read More »
This story originally appeared on The Fresh Toast. As cannabis becomes a go-to source for a myriad of health benefits, celebrity endorsements are normalizing the herb more than ever. Legally speaking, cannabis has slowly been making progress, shifting our cultural perspective so much so that it seems like celebrities openly …Read More »
This story originally appeared on Forbes. Federal Legalization Could Happen If Democrats Win Georgia’s Two Senate Seats In the January Run-off. Recreational and medical cannabis use ballot victories across the political spectrum this fall show marijuana’s acceptance continues to grow among American voters. Still, politicians mostly act along party lines. …Read More »
This story originally appeared on TheGrowthOp. The Thai government has proposed plans to remove the leaves, branches, stems, trunks, bark, fibre and roots of cannabis and hemp plants from the government’s narcotics list, opening the door for infused cosmetics and food products, reports the Bangkok Post. Notably, cannabis flower will remain …Read More »
This story originally appeared on The Growth Op. Ontario’s MediPharm Labs Corp. has launched a new line of THC-free, 99 per cent pure CBD crystalline isolate to be sold under the LABS Cannabis banner. According to a press release, it’s the first product of its kind in Canada. “Produced at commercial scale, …Read More »
This story originally appeared on Marijuana Stocks. Will These Pot Stocks Make Big Gains Next Year? 2020 has been a wild year for marijuana stocks to say the least. With Covid, a stimulus package, and environmental issues striking the U.S. economy, it’s hard to predict where the future will be for the cannabis industry. …Read More »
This story originally appeared on The Growth Op. The results are in from more than two months of public consultations by Health Canada regarding cannabis health products, with more than 60 per cent of respondents indicating that they would be interested in such items. Health Canada reports it will now create a …Read More »
This story originally appeared on The Growth Op. To some, artificial intelligence (AI) may be categorized next to the likes of Bitcoin and blockchain: it’s just another techie buzz word. For others, artificial intelligence could conjure up images of sentient robots hellbent on world domination. While artificial intelligence, in some ways, can …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!